Effects of intensive lipid lowering compared with moderate-intensity lipid lowering on coronary atherosclerotic plaque phenotype and major adverse cardiovascular events in adults with low to intermediate 10-year ASCVD risk (ILLUMINATION study): protocol for a multicentre, open-label, blinded-endpoint, randomised controlled trial.
Jianan ZhengZhihui HouJinqing YuanXueyan ZhaoYang WangJia LiWenjia ZhangKe-Fei DouBin LuPublished in: BMJ open (2023)
NCT05462262.
Keyphrases
- cardiovascular events
- coronary artery disease
- study protocol
- open label
- high intensity
- randomized controlled trial
- clinical trial
- cardiovascular disease
- fatty acid
- phase ii
- phase iii
- phase ii study
- placebo controlled
- squamous cell carcinoma
- double blind
- type diabetes
- emergency department
- aortic stenosis
- heart failure
- adverse drug
- electronic health record
- aortic valve